Clinical Updates

The U.S. DEA Proposes Production Cuts to Five Opioids in 2020
The U.S. DEA Proposes Production Cuts to Five Opioids in 2020

The U.S. DEA (Drug Enforcement Administration) released a Notice of Proposed Rulemaking in the Federal…

Sep 16, 2019
Generic Launch of Rozerem
Generic Launch of Rozerem

The generic equivalent of Rozerem (Ramelteon) is now available. Rozerem is FDA approved for the…

Jul 29, 2019
Launch of Generic Lyrica
Launch of Generic Lyrica

The U.S. Food and Drug Administration (FDA) has approved the launch of generic Lyrica (pregabalin)….

Jul 24, 2019
Gabapentin to Become A Controlled Substance in Alabama

By: Heidi Dufrene, PharmD   Recently, the Alabama State Committee of Public Health voted to…

Jul 16, 2019
Gabapentin to Become a Controlled Substance in Virginia
Gabapentin to Become a Controlled Substance in Virginia

The 2019 Virginia General Assembly recently passed a new bill that will classify gabapentin as…

Jun 10, 2019
Launch of Generic Proventil HFA
Launch of Generic Proventil HFA

The generic equivalent of Proventil HFA (Albuterol HFA) is now available. Proventil HFA is FDA…

May 21, 2019
Launch of Generic Vesicare

By: Heidi Dufrene, PharmD The generic equivalent of Vesicare (Solifenacin succinate) is now available. Vesicare…

Apr 26, 2019
Launch of Generic Flector Patch

By: Heidi Dufrene, PharmD The generic equivalent of Flector Patch (Diclofenac Epolamine) is now available….

Mar 13, 2019
Launch of Generic Amrix

By: Heidi Dufrene, PharmD The generic equivalent of Amrix (cyclobenzaprine ER) is now available. Amrix…

Mar 11, 2019
Launch of Generic Ranexa

By: Heidi Dufrene, PharmD The generic equivalent of Ranexa (ranolazine) is now available. Ranexa is…

Mar 05, 2019
  • This field is for validation purposes and should be left unchanged.


Filter Articles

Should a claimant need this much pain medication for this long? Are claimants utilizing medications or selling on the black market?

The prevalence of opioid use and abuse among those with chronic pain has developed into one of the most pressing issues today. Download the white paper to learn facts about the opioid crisis and possible solutions to avoid prescriptions that could lead to abuse.

Download Now